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Abstract
Background: Hexavalent chromium is a known carcinogen when inhaled, but its carcinogenic potential when
orally ingested remains controversial. Water contaminated with hexavalent chromium is a worldwide problem,
making this a question of significant public health importance.
Methods: We conducted an ecological mortality study within the Oinofita region of Greece, where water has been
contaminated with hexavalent chromium. We calculated gender, age, and period standardized mortality ratios
(SMRs) for all deaths, cancer deaths, and specific cancer types of Oinofita residents over an 11-year period (1999 -
2009), using the greater prefecture of Voiotia as the standard population.
Results: A total of 474 deaths were observed. The SMR for all cause mortality was 98 (95% CI 89-107) and for all
cancer mortality 114 (95% CI 94-136). The SMR for primary liver cancer was 1104 (95% CI 405-2403, p-value <
0.001). Furthermore, statistically significantly higher SMRs were identified for lung cancer (SMR = 145, 95% CI 100-
203, p-value = 0.047) and cancer of the kidney and other genitourinary organs among women (SMR = 368, 95% CI
119-858, p-value = 0.025). Elevated SMRs for several other cancers were also noted (lip, oral cavity and pharynx 344,
stomach 121, female breast 134, prostate 128, and leukaemias 168), but these did not reach statistical significance.
Conclusions: Elevated cancer mortality in the Oinofita area of Greece supports the hypothesis of hexavalent
chromium carcinogenicity via the oral ingestion pathway of exposure. Further studies are needed to determine
whether this association is causal, and to establish preventive guidelines and public health recommendations.
Background
Hexavalent chromium Cr(VI) is recognized by the
World Health Organization (WHO) as a human carci-
nogen through inhalation [1], but there is significant
debate on the carcinogenicity of hexavalent chromium
when it is orally ingested. In a recent article using data
from the National Toxicology Program (NTP) of the
National Institutes of Health, hexavalent chromium was
identified as ‘likely to be a carcinogen to humans’ with
an estimate of the cancer potency to humans equal to
0.5 (mg/kg/day)
-1 [2].
At the cellular level, Cr(VI) is a highly active carcino-
gen [3,4]. A key issue is whether Cr(VI) ingested
through the oral route, converts to trivalent Chromium
Cr(III) (which does not cross the cell membrane that
easily) before entering a living cell [5]. A recent study
[6] revealed that rats and mice exposed to Cr(VI)-con-
taminated drinking water developed gastrointestinal
abnormalities, including oral and intestinal tumors. An
earlier study [7] also found an increased incidence of
benign and malignant combined forestomach neoplasms
in mice orally exposed to Cr(VI), whereas a more recent
publication [8] presented a physiologically based model
of chromium kinetics according to which non reduced
hexavalent chromium after oral exposure could be meta-
bolized in the red blood cells, liver, kidney and bone.
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tions in drinking water are relatively uncommon, human
epidemiologic studies are scant. One of the most cited
and controversial studies analyzing the effects of oral
exposure to Cr(VI) on population cancer mortality rates
was conducted near a chromium smelting plant in the
Liaoning Province, China [9]. Elevated mortality rates for
total cancer, lung cancer, and stomach cancer were
noted. These data were re-analyzed and re-evaluated by
other investigators [10,11]; their re-analysis supported
the conclusions of the original study [12,13]. However, a
different study [14], comparing the same exposed villages
to those of nearby areas, concluded that on average, the
mortality rates for lung, stomach, and total cancer were
not statistically different. Thus, based on ecologic studies
and animal studies, one could hypothesize that several
organs could be targets of chromium carcinogenicity
including the liver, kidney, bladder, gastrointestinal tract,
the hematopoietic system and even bone.
In order to further examine the potential effects of
elevated oral exposure to hexavalent chromium, we per-
formed an ecological mortality study in an industrial
area of Greece where the water consumed by the popu-
lation was contaminated with hexavalent chromium
(maximum levels ranging between 41 and 156 μg/l in
2007-2009, and presumed exposure for at least 20
years). Therefore, the goal of this study was to examine
the cancer mortality in an area of Greece, historically
satisfying its potable needs with a Cr(VI)-contaminated
aquifer.
Methods
Study area location and exposure
The Oinofita municipality (Figure 1) is situated 50 km
north of Athens, Greece and is comprised of four vil-
lages that were initially rural but transformed into
industrial areas in the early 1970s. In 1969, a ministerial
decision gave permission for depositing processed indus-
trial waste in the Asopos river, which runs through
Oinofita. This decision, furthered by a presidential
decree in 1979, permitted free disposal of processed
liquid industrial waste into the river.
The Oinofita industrial region is located within Voio-
t i ap r e f e c t u r ea tt h eb o r d e ro fA t t i c ap r e f e c t u r e( t h a t
includes the capital city of Athens). Due to the proxi-
mity to Attica, the number of industries in the Oinofita
region increased precipitously after 1984, when a new
law imposed restrictions on the establishment of various
industries within Attica. According to the Technical
Chamber of Greece [15], in 2009, there were about 700
industries operating in the Oinofita area, of which 500
generated liquid industrial waste.
Initial concerns were raised after Oinofita area citizens
complained about the discoloration and turbidity of their
drinking water. Regular protests ensued from the 1990s
onward. In 2007, the Ministry of Environment, Regional
Planning and Public Works of Greece imposed fines on
20 industries for disposing industrial waste with high
levels of hexavalent chromium into the Asopos river.
Official limits on total chromium have been set by
both the United States Environmental Protection
Agency (EPA), equal to 100 μg/l, and the European
Union (Council directive 98/83/EC), equal to 50 μg/l.
However, as of yet, there are no limits set by any inter-
national body for Cr(VI). In 2009, the California Envir-
onmental Protection Agency proposed a public health
goal level of 0.06 μg/l for Cr(VI) in drinking water [16].
Since 2007, three independent sets of hexavalent chro-
mium measurements are available for the Oinofita area.
These include: a) a study of the Institute of Geology and
Mineral Exploration (IGME) [17] during the period
November 2007 to February 2008, which detected 35
samples (out of 87) taken from different wells in the
Figure 1 Map of the Oinofita municipality (study area) in
Greece. Panel A: Oinofita municipality lies at the border of the
Voiotia with the Attica prefecture. Panel B: Oinofita municipality is
comprised of four villages: Klidi, Agios Thomas, Oinofita and Dilesi.
The high industrial concentration near Asopos river can also be
observed.
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value 156 μg/l; b) a study conducted by faculty of the
Geology and Geo-environment department of the Uni-
versity of Athens [18] during the period September 2008
to December 2008, in which Cr(VI) levels ranged from
41 up to 53 μg/l in three samples taken from the public
drinking water supply of Oinofita; and c) repeated mea-
surements from the Oinofita municipality in the public
drinking water supply during the period July 2007 to
July 2010, in which there are 13 measurements with
levels above 10 μg/l and with a maximum value of 51 μg/
l. Notably all 16 measurements made in 2007 and 2008
by the Oinofita municipality, record hexavalent chro-
mium levels above 8 μg/l (Table 1). According to official
Oinofita municipality authorities, in early 2009 the main
drinking water supply of Oinofita was diverted to receive
water from Mornos lake (reservoir) which is part of the
d r i n k i n gw a t e rs u p p l yn e t w o r ko ft h ec i t yo fA t h e n s .
Therefore, more recent measurements made by the
Oinofita municipality (June 2009- July 2010) record rela-
tively lower levels of Cr(VI) (<0.01-1.53 μg/l). To the best
of our knowledge, there are no systematic measurements
of Cr(VI) before 2007. However, a measurement made by
the Oinofita municipality in 1996, showed Cr(VI) levels
of 54 μg/l in the public drinking water supply.
Study population
Using municipality records, we identified 5842 indivi-
duals who met the following criteria: a) being a legally
registered citizen of the municipality at any time during
the follow up period (1/1/1999 - 31/12/2009) and b)
being registered as a permanent resident of Oinofita in
the municipality records. The date 1/1/1999 was
selected due to the fact that the municipality’s vital sta-
tistics department maintained death certificates in a sys-
tematic way only after 1/1/1999.
In order to identify these individuals, we first obtained
electronic records of all persons ever (since 1855) legally
registered in the municipality. Greek municipality
records are maintained in family units. A person
remains in his/her family record from birth until mar-
riage or until registering in another municipality. At the
time of marriage a new record is created for the couple,
and their children are included in that same record. In
case of divorce, two new records are created and chil-
dren may be included in either of the parents’ records.
This way each individual may have multiple records
based on whether he/she has been married, divorced, or
changed municipalities through the years. Furthermore,
in Greece one can move into a new place of residence
without registering into the new municipality, but rather
maintaining his/her initial municipality record. Thus, it
was essential for our study design to exclude individuals
registered in the Oinofita municipality but living outside
the municipality. The municipality records provide the
information of whether a person is a permanent resident
or has moved outside the municipality. Thus we selected
persons fulfilling both criteria “a” and “b” to include in
the study design. The original file with municipality
records of Oinofita contained 13,582 records referring
to a total of 8872 individuals. We merged the informa-
tion of all records on each person into a single record
per individual for the analysis.
Of the potentially eligible 8872 persons identified,
1958 did not meet the criterion of being registered citi-
zens of Oinofita municipality at any time between 1/1/
1999-31/12/2009, whereas an additional 1072 were
excluded because they did not meet the residence criter-
ion. Therefore, the resulting cohort was comprised of
5842 individuals.
The beginning of follow up period for each individual
was set as either a) January 1, 1999 for individuals regis-
tered in the municipality before this date, or b) the date
of registration in the municipality for those registered
after January 1, 1999. The end of the follow up was set
as either a) the date of death or the date of deletion
from the records because of registering to another
municipality before December 31, 2009, or b) December
31, 2009. The dates of death were cross-checked with
the corresponding death certificates of each individual,
which were obtained from the local vital statistics regis-
try and from burial records of the local church. The
cause of death was coded using the four-digit ICD-9
Table 1 Hexavalent chromium measurements in different
sites of the public drinking water supply of the Oinofita
municipality during the period July 2007- June 2008
Sample Date Site Level (μg/l)
1 24/7/2007 1 43
2 24/7/2007 2 51
3 24/7/2007 3 50
4 24/7/2007 4 47.9
5 24/7/2007 5 26.2
6 24/7/2007 6 27.9
7 26/10/2007 7 28
8 26/10/2007 8 10
9 8/11/2007 1 43
10 8/11/2007 9 10
11 29/11/2007 8 39
12 6/12/2007 9 11
13 6/12/2007 1 44
14 6/12/2007 10 12
15 16/6/2008 11 42.8
16 16/6/2008 12 8.3
Source: Oinofita municipality
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(eight) persons who had changed municipality and then
re-registered in the Oinofita municipality during the
study period, we counted only the person years during
which they were formally registered in the municipality.
Statistical analysis
We calculated person years, stratified by gender, age (in
five year groups), and calendar year. We also calculated
observed deaths for all causes, overall cancer, and site
specific cancers, stratified by gender, age, and calendar
year.
The expected number of deaths was calculated based
on mortality statistics of the entire Voiotia prefecture, in
which Oinofita municipality belongs to. Voiotia prefec-
ture includes 20 municipalities, and had an average
population size of approximately 125,000 during the
years of interest. We chose Voiotia prefecture, because
of the similar geographical, population density, socioeco-
nomic, and ethnic origin characteristics of the
population.
The population statistics for Voiotia, as well as the
cause specific deaths (coded from original death certifi-
cates), stratified by gender, age, and calendar year, were
provided by the Hellenic Statistical Authority. Hence,
we were able to calculate the corresponding all cause
and cause specific mortality rates by gender, age, and
calendar year for the Voiotia prefecture.
Standardized Mortality Ratios (SMRs) were computed,
stratified by age (in five-year age groups), gender and
calendar year, by dividing the observed number of
deaths with the expected number of deaths (multiplied
by 100). The expected deaths were obtained by multi-
plying the corresponding person years with the age-gen-
der-year and cause specific mortality rate of the Voiotia
prefecture population. In the analysis, we reduced the
four-digit ICD-9 code to a three-digit level classification
system similar to what is used by the Hellenic Statistical
Authority [19]. We used SPSS 17 and confirmed results
using Stata 10. We calculated 95% confidence intervals
and p-values for the SMRs on the basis of the exact
Poisson method [20,21].
Tests of linear trend were performed (under the Chi-
square distribution) [22], after computing cause specific
SMRs (adjusted for age and gender) for each year of fol-
low up. The reason was to use years of follow up as a
proxy to exposure level (dose). Thus a linear trend (if
existing) would be in accordance with a dose/response
relationship taking into account latency period as well.
Although municipality records do not specify the village
in which each individual resides, we obtained this infor-
mation from the death certificates. Thus, we were able
to calculate proportional mortality ratios (PMRs)
(adjusted for age and gender) of cause specific deaths
versus all deaths, for specific Oinofita villages compared
to those of the Voiotia prefecture.
Results
The number of total deaths, cancer deaths, and persons
years (total and within each age group), stratified by
gender and calendar year are presented in Table 2.
More than 50% of the person years calculated corre-
sponded to age groups under 40, while the percentages
of male and female did not substantially differ. The per-
son years were decreasing as a function of time, showing
5232 and 4632 person years in 2000 and 2009, respec-
tively. Thus, the rate at which persons exit the cohort
surpasses the corresponding entry rate. Furthermore, it
is interesting to note that in 2009 there were more can-
cer deaths than ever before (18 compared to 4-13 as
observed in previous years).
A total of 474 deaths were observed, of which 118 were
cancer related (Table 3). These figures (i.e. one in four
deaths being cancer related) are in accordance to the
general Greek, EU15 and EU27 averages [23]. The all
cause SMR for the Oinofita municipality was similar to
that of the prefecture of Voiotia (SMR = 98, 95% CI 89-
107). The SMR for all cancer deaths over all years was
slightly increased but not statistically significantly (SMR
= 114, 95% CI 94-136). There were eight observed deaths
of the hepatobiliary system, and more specifically: six pri-
mary liver cancers, one bile duct, and one gallbladder.
For primary liver cancer, the observed deaths were eleven
fold higher than the expected number of deaths (SMR
1104, 95% CI 405-2403, p < 0.001); statistically significant
SMRs for primary liver cancer were observed among
both males and females. Observed deaths associated with
kidney and other genitourinary organ cancers (five deaths
with ICD-9 code 189, and one death with ICD-9 code
184) were more than threefold higher than expected in
women (SMR 368, 95% CI 119-858, p = 0.025). The SMR
for lung cancer was also statistically significantly elevated
(SMR 145, 95% CI 101-203, p = 0.047). Furthermore, ele-
vated SMRs were noted for several other cancer sites,
including cancers of lip, oral cavity and pharynx, sto-
mach, female colon, female breast, prostate, and leukae-
mia, but did not reach statistical significance (Table 3).
Tests for linear trend performed after grouping the
period specific SMRs into 3 time intervals, i.e. 1999-
2002, 2003-2006, 2007-2009, did not reveal any signifi-
cant evidence of a linear trend. However, as depicted in
Figure 2, there was a statistically significant SMR of 193
(95% CI 114-304, p = 0.015) for all cancer deaths that
was found for the year 2009.
Further, we noted that three out of the six deaths
associated with primary liver cancer and two out of the
five deaths associated with female kidney and other gen-
itourinary organ cancers came from the small village of
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nent residents, according to the 2001 population cen-
sus). The PMR for primary liver cancer for Agios
Thomas compared to Voiotia prefecture was equal to
1629 (95% CI 336-4762, p = 0.002), while the PMR for
female kidney and other genitourinary organs cancer
was equal to 442 (95% CI 53-1595, p = 0.153). Of inter-
est, in measurements made by the Institute of Geology
and Mineral Exploration in 2008, the highest concentra-
tion of hexavalent chromium (156 μg/l) was found in a
well close to the village of Agios Thomas.
Discussion
There is considerable debate on the potential health
effects of oral exposure to Cr(VI). Based on available
evidence [7-11] the California Environmental Protection
Agency [24] decided to establish a criterion of 0.2 μg/l
for Cr(VI) as the maximum level in drinking water in
1999. However, this criterion was withdrawn in 2001
after reviewing the weight-of-evidence [4], and
concluding that there was insufficient data to consider
Cr(VI) a carcinogen via the oral route. Given the
absence of adequate evidence, the California Congres-
sional Delegation, California Environmental Protection
Agency, and California Department of Health Services
nominated Cr(VI) for toxicity and carcinogenicity test-
ing to the National Toxicology Program (NTP). The
NTP results published recently [6] report that rats and
mice exposed to drinking water with Cr(VI) developed
oral cavity neoplasms, small intestine neoplasms and
hyperplasia, and displayed a significant increase in his-
tiocytic cell infiltration in the duodenum, jejunum, and
liver as well as in mesenteric and pancreatic lymph
nodes. This evidence contributed to the proposal of the
California Environmental Protection Agency to set a
public health goal (0.06 μg/l) for Cr(VI) in drinking
water in August 2009 [16]. Hexavalent chromium was
further recognized as ‘likely to be carcinogen to humans’
recently and the cancer potency to humans was esti-
mated to be equal to 0.5 (mg/kg/day)
-1 (Stern, 2010).
Table 2 Total deaths, Cancer deaths and Person years age distribution, stratified by gender and calendar year
Year 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 Total
Age distribution (% Person years) TOTAL
0-19 22.5 22.7 21.9 21.5 20.9 20.2 19.8 19.2 19.2 19.0 19.3 20.6
20-39 31.9 31.7 31.8 31.9 32.0 32.4 32.2 32.1 31.2 31.1 29.8 31.7
40-59 26.2 25.8 26.0 25.7 26.0 25.7 25.6 25.3 25.4 25.3 25.6 25.7
60-79 16.7 17.1 17.6 18.4 18.6 19.1 19.5 20.2 20.6 20.9 21.4 19.1
>80 2.7 2.7 2.6 2.4 2.4 2.7 2.8 3.3 3.7 3.7 3.8 3.0
Person years 5109.5 5232.2 5213.6 5148.0 5081.8 5037.7 4979.4 4871.2 4780.1 4717.0 4632.5 54,803.1
Total deaths 36 40 47 47 36 47 39 34 52 44 52 474
Cancer deaths 4 13 7 12 9 9 12 11 11 12 18 118
Age distribution (% Person years) MALE
0-19 22.7 23.6 22.7 22.1 21.7 21.1 20.6 20.3 20.1 19.7 20.0 21.4
20-39 32.0 31.2 31.3 32.0 32.1 32.5 32.4 32.2 31.4 31.6 30.7 31.8
40-59 26.1 25.9 25.8 25.6 25.9 25.3 25.5 24.8 25.2 25.1 25.5 25.5
60-79 17.4 17.6 18.2 18.6 18.7 19.1 19.2 20.0 20.1 20.2 20.2 19.0
>80 1.9 1.8 1.8 1.7 1.6 2.1 2.2 2.7 3.1 3.4 3.6 2.3
Person years 2531.5 2597.8 2587.7 2554.2 2527.8 2513.1 2481.4 2421.4 2369.5 2341.1 2295.6 27.221.0
Total deaths 19 24 29 27 17 22 26 20 27 27 29 267
Cancer deaths 2 8 7 8 6 3 10 8 5 8 11 76
Age distribution (% Person years) FEMALE
0-19 22.3 21.8 21.1 21.0 20.1 19.3 19.0 18.2 18.3 18.3 18.7 19.9
20-39 31.9 32.3 32.3 31.9 32.0 32.3 31.9 31.9 31.0 30.6 29.0 31.6
40-59 26.4 25.6 26.1 25.7 26.2 26.0 25.8 25.8 25.6 25.4 25.6 25.8
60-79 16.0 16.7 17.0 18.3 18.5 19.2 19.8 20.3 21.0 21.7 22.6 19.1
>80 3.5 3.5 3.4 3.2 3.3 3.3 3.4 3.8 4.2 4.1 4.1 3.6
Person years 2578.0 2634.4 2625.9 2593.8 2554.0 2524.6 2498.0 2449.8 2410.6 2375.9 2336.9 27,582.0
Total deaths 17 16 18 20 19 25 13 14 25 17 23 207
Cancer deaths 2 5 0 4 3 6 2 3 6 4 7 42
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gave us the opportunity to evaluate the potential
effects of hexavalent chromium on mortality rates.
Though based on small numbers, our data raise con-
cerns as to the possibility of higher mortality rates
from primary liver and lung cancers in both males
and females as well as urologic cancers among
women, but undoubtedly further research in the area
is warranted. Comparisons between genders are hard
given the small numbers of observed and expected
numbers of deaths, thus partly explaining the non
consistent finding of increased urologic cancers only
among female. Further, our results suggest possibly
higher risk of other epithelial and gastrointestinal
cancers. These findings are consistent with previous
epidemiological and animal studies indicating carcino-
genesis after consumption of drinking water contami-
n a t e dw i t hC r ( V I )[ 6 - 1 1 ] .
Table 3 Observed deaths, SMRs with 95% CI and p-values, stratified by gender and cancer type; Oinofita vs. Voiotia
TOTAL MALE FEMALE
Cause of death ICD-9
range
Obs. SMR 95% CI p-
value
Obs. SMR 95% CI p-
value
Obs. SMR 95% CI p-
value
Total deaths 474 97.9 89.3 107.1 0.661 267 108.0 95.5 121.8 0.219 207 87.3 75.8 100.0 0.502
Cancer deaths 140-208 118 113.6 94.1 136.1 0.184 76 113.6 89.5 142.2 0.293 42 113.7 81.9 153.6 0.447
Lip, oral cavity
and pharynx
140-149 3 344.1 71.0 1005.7 0.117 3 468.7* 96.6 1369.6 0.055
Stomach 151 6 120.9 44.4 263.2 0.755 4 115.6 31.5 296.1 0.909 2 133.1 16.1 480.8 0.886
Colon 153 6 83.5 30.6 181.7 0.844 1 27.7 0.7 154.3 0.249 5 139.8 45.4 326.2 0.578
Liver primary 155.0 6 1104.2** 405.2 2403.3 <0.001 4 811.7** 221.2 2078.3 0.003 2 3952.3** 478.6 14277.0 0.002
Pancreas 157 6 85.0 31.2 185.0 0.882 4 87.9 24.0 225.1 1.000 2 79.7 9.7 288.0 1.000
Gallbladder and
other digestive
organs and
peritoneum
155.1,
155.2,
156,
158-159
4 41.6 11.3 106.5 0.075 2 32.3 3.9 116.7 0.108 2 58.3 7.1 210.8 0.669
Lung, trachea
and bronchus
162 34 145.1** 100.5 202.8 0.047 29 141.9* 95.0 203.8 0.086 5 166.7 54.1 389.1 0.369
Other respiratory
system and
intrathoracic
organs
160,
163-165
2 445.1 53.9 1608.0 0.150 2 693.3* 84.0 2504.3 0.069
Bone and
articular cartilage
170 1 128.6 3.3 716.7 1.000 1 193.0 4.9 1075.4 0.809
Malignant
melanoma of skin
172 1 143.6 3.6 800.1 1.000 1 214.9 5.4 1197.2 0.744
Female breast 174 9 133.6 61.1 253.5 0.475 9 133.6 61.1 253.5 0.475
Cervix uteri 180 1 412.1 10.4 2296.1 0.431 1 412.1 10.4 2296.1 0.431
Prostate 185 7 127.9 51.4 263.5 0.620 7 127.9 51.4 263.5 0.620
Testis 186 1 2141.5* 54.2 11931.5 0.091 1 2141.5* 54.2 11931.5 0.091
Bladder 188 3 82.1 16.9 240.1 1.000 2 65.4 7.9 236.3 0.821 1 168.3 4.3 937.8 0.896
Kidney and other
genitourinary
organs
184,
187,
189
6 203.5 74.7 442.9 0.158 1 62.9 1.6 350.6 1.000 5 367.8** 119.4 858.3 0.025
Brain 191 4 89.4 24.4 229.0 1.000 3 107.2 22.1 313.3 1.000 1 59.8 1.5 332.9 1.000
Other and
unspecified
malignant
neoplasm
190,
192-199
9 88.0 40.2 167.0 0.859 4 71.1 19.4 182.1 0.677 5 108.5 35.2 253.3 0.976
Leukaemias 204-208 7 167.6 67.4 345.4 0.260 5 172.8 56.1 403.4 0.334 2 155.8 18.9 562.9 0.735
Other lymphoid
and
hematopoietic
tissue
200,
202-203
2 82.2 10.0 297.1 1.000 2 182.8 22.1 660.2 0.598
Notes: * Statistically significant at 10% level. ** Statistically significant at 5% level. Types of cancer are classified according to the Hellenic Statistical Authority [17].
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was based on an ecologic comparison. Thus, exposure is
expressed as residing in the area assuming that all resi-
dents consumed water provided by the municipality.
Well water is very rarely used for drinking in Greece
and the level of contamination is very similar. Another
water source could be bottled water thus leading to
lower actual exposure and therefore underestimation of
the risk. Furthermore, it is not possible to exclude the
presence of confounding factors such as occupational
exposures and cigarette smoking. Indeed, these factors
could account for the modestly increased SMRs for lung
cancer in the region; however, one would have expected
all causes of death to be elevated if this were true, but
this was not observed. Another potential confounder is
the presence of medical conditions requiring use of
anti-acids and leading to lower rate of reduction of hex-
avalent chromium to trivalent. We have no indications
that use of anti-acids is unusual in this population. The
presence of other contaminants in water is an alterna-
tive explanation. Yet, none of the available measure-
ments revealed high concentrations in other substances.
Only modest levels of arsenic were detected but not
consistently (levels 0-9 μg/l in 2007, 0-22 μg/l in 2008,
and 0-2 μg/l in 2009). Moreover, the elevated mortality
rates for primary liver cancer are difficult to attribute
fully to these other factors. An additional potential pro-
blem would be the misclassification of the cause of
death e.g. attributing deaths to liver cancer or kidney
cancer when the real underlying cause of death was
another disease. We eliminated this potential bias by
scrutinizing all death certificates and excluding all meta-
static liver cancers. Similar scrutiny was not undertaken
in the comparison group. Thus, we would expect that
the estimated SMRs would only underestimate the real
risk. We also have no reason to believe that misclassifi-
cation regarding cause of death would be differential
between the exposed population and the control
population given that the population is of similar socioe-
conomic level and served by the same medical services
(National Health System). So any misclassification in the
cause of death would be random thus not overestimat-
ing risk.
In our methodology we allowed persons that entered
the municipality after the beginning of follow up to be
included in the cohort, thus including persons with very
low latency period in our population. From the 5842
individuals in the cohort, 753 registered into the munici-
pality after the start of the follow up period 1/1/1999.
The majority (540) were children born between 1/1/
1999 and 31/12/2009. The total additional person years
(including those contributed by the children) were 4478.
Among members of this sub cohort three lung cancer
deaths in 2001, 2004 and 2007 (occurring in persons
that entered the cohort in 1999 and 2000) were
observed in the period under examination. The inclu-
sion of this sub cohort can only have led to underesti-
mation of the risk for all types of cancer except possibly
for lung cancer.
Overall the main limitation of our study is the dura-
tion of follow-up. In our data, the overall SMRs for
Oinofita appeared to rise in recent years. Thus, longer
follow-up, along with better characterization of Cr(VI)
exposure, by focusing on specific chromium biomarkers,
would help understand whether this trend would
continue.
Conclusions
Water contaminated with hexavalent chromium has
been suggested as a potential carcinogen in humans
through the oral route. This study provides further evi-
dence of this relationship. In light of the potentially
widespread health implications of such contamination,
further studies are critically needed to explore the possi-
ble causal link between exposure to hexavalent chro-
mium through drinking water and cancer risk. Such
evidence is needed to establish guidelines for the pre-
vention of this form of contamination and formulate
public health recommendations.
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